Disappointing News in the Fight Against Alzheimer’s Disease
The latest hoped-for breakthrough drug in the fight against Alzheimer’s has been scrapped. But all is not quite as bleak as it might seem: drugs like bapineuzumab might still prove useful as an early intervention vehicle, possibly preventing plaques from forming and building up in the brains of individuals who show early signs of cognitive problems thought to be precursors of Alzheimer’s.
